NCT01459757

Non-Interventional Retrospective Correlation Of Tumor Mutational Status To Clinical Benefit Of GIST Patients Treated With Sunitinib

A Non-Interventional Retrospective Correlation Of Tumor Mutation Status To Clinical Benefit From The SU011248, A6181036 Treatment Protocol Titled: A Treatment Protocol For Patients With Gastrointestinal Stromal Tumor Who Are Ineligible For Participation In Other SU011248 Protocols And Are Refractory To Or Intolerant Of Imatinib Mesylate

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 322 (actual)
• Sponsor: Pfizer · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Retrospective correlation of clinical outcomes data with mutational status in GIST subjects treated with sunitinib.

Detailed description

This is a non-interventional trial. No active patients will participate in this study. Only data generated from the A6181036 study will be utilized for correlational purposes. The A6181036 study data in addition to mutational status data previously analyzed but not collected as part of the A6181036 study in the same patient population

Conditions

• GIST

Interventions

Type	Name	Description
OTHER	non-interventional	Non-interventional; Mutational status data analyzed previously but not collected in the A6181036 study, will be correlated wth A6181036 clinical outcomes data collected during the A6181036 study.

Timeline

• Start date: 2011-10-01
• Primary completion: 2013-04-01
• Completion: 2013-04-01
• First posted: 2011-10-26
• Last updated: 2013-06-19

Locations

36 sites across 16 countries: United States, Australia, Belgium, Canada, Denmark, Finland, France, Germany, India, Netherlands, Poland, Slovakia, South Korea, Spain, Switzerland, United Kingdom